Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the same
申请人:Nakamura Keiji
公开号:US20100093771A1
公开(公告)日:2010-04-15
The present invention relates to a bicyclic pyrimidine compound of the following formula (I) or a salt thereof.
wherein R
1
is lower alkyl, cyclic lower alkyl. etc.; R
2
is H, lower alkyl, lower alkenyl, etc.; R
3
is H, lower alkyl, lower alkenyl, etc.; X is O, S or —N(R
4
)—; R
4
is H or lower, alkyl; or R
2
and R
4
may combine each other to form cyclic amino; Y is amido, keto, sulfonyl, etc.; R
5
is H or lower alkyl; Z is O or S; m and n are 1 or 2. Said compound (I) or a salt thereof have MGAT inhibitory activity, and are useful as an agent for treatment or prophylaxis of adiposity, metabolic syndromes, hyperlipidemia, hyper neutral lipemia, hyper VLDL-mia, hyper fatty acidemia, diabetes mellitus, arteriosclerosis.